+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hybrid Imaging Market - Global Forecast 2026-2032- Product Image
Hybrid Imaging Market - Global Forecast 2026-2032- Product Image
New

Hybrid Imaging Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674560
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Hybrid imaging is redefining clinical diagnostics by bridging molecular and anatomical insights for improved precision, efficiency, and integrated care delivery. As technology and clinical demands evolve, business leaders must navigate shifting adoption pathways, supply chain dependencies, and strategic opportunities to secure competitive and operational advantage in this fast-advancing field.

Market Snapshot: Hybrid Imaging Market Size & Growth

The hybrid imaging market grew from USD 8.60 billion in 2025 to USD 9.19 billion in 2026 and is projected to expand at a compound annual growth rate of 6.90%, ultimately reaching USD 13.72 billion by 2032. Growth is driven by advances that have transitioned hybrid imaging from niche research applications into everyday clinical use and by increasing demand for protocols that combine functional and structural information in a single session. Market expansion reflects clinical requirements for precise diagnosis and operational pressures to optimize workflow across healthcare settings.

Scope & Segmentation of the Hybrid Imaging Market

  • Technology Types: PET-CT, PET-MRI, and SPECT-CT, each offering distinct balances of sensitivity, resolution, and throughput aligned with specialty workflows.
  • Sales Channels: Direct sales and distributors, which affect procurement cycles, bundled service options, and the degree of local support available for customers.
  • Applications: Cardiology (including Myocardial Perfusion and Viability), Infectious Diseases (Infection Site Imaging, Inflammation Imaging), Neurology (Epilepsy, Neurodegenerative disorders), Oncology (Hematologic Malignancies, Solid Tumors). Application-focused segmentation informs protocol development and tracer selection.
  • End Users: Diagnostic centers, hospitals, and research institutes. Each group displays unique priorities in terms of capital allocation, throughput needs, and workflow optimization.
  • Regional Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific. These regions vary by infrastructure maturity, regulatory landscape, and local manufacturing capacity, shaping adoption strategies.

Key Takeaways for Hybrid Imaging Investment

  • Integrated hybrid platforms now form the foundation for advanced, cross-disciplinary clinical protocols that support multiple specialties within healthcare systems.
  • Ongoing technological progress in detectors, radiotracer chemistry, and software is expanding both clinical use cases and operational efficiencies for providers.
  • Cross-functional governance that includes clinical, technical, and operational leaders accelerates successful adoption by aligning technology selection with clinical needs.
  • Strategic partnerships between OEMs, radiopharmaceutical suppliers, and digital health players are driving bundled solutions and validated clinical pathways.
  • The competitive landscape is shifting toward lifecycle support, emphasizing supply chain transparency, workforce training, and long-term collaboration over single-transaction sales.
  • Segmentation analysis reveals new opportunities for vendors to tailor platform offerings by specialty, channel, and regional regulatory requirements.

Tariff Impact: Procurement & Supply Chain Considerations

Changing tariffs and global trade policies directly influence procurement costs and supply chain resilience for hybrid imaging systems. Fluctuating import duties on core devices, components, and radiopharmaceuticals can affect landed costs and service pricing. Providers are prioritizing supply agreements that emphasize transparent sourcing strategies, risk mitigation through local inventory, and robust maintenance support to sustain operational continuity and predictable total cost of ownership. These dynamics elevate the importance of contractual resilience and vendor relationships that can adapt to geopolitical uncertainties.

Methodology & Data Sources

This report’s findings are informed by in-depth interviews with clinical and commercial experts, triangulation of peer-reviewed literature, and analysis of regulatory and technical documents. The research integrates case studies from leading clinical sites and scenario assessments of supply chain impacts to deliver practical, validated insights for executive decision-making.

Why This Report Matters

  • Supports executive decisions by aligning investment in hybrid imaging with clinical, operational, and financial objectives across diverse provider settings.
  • Enables risk mitigation, robust procurement, and long-term vendor strategy in fluctuating global trade environments.
  • Provides actionable intelligence to inform cross-functional governance, technology selection, and regional market entry planning.

Conclusion

Establishing hybrid imaging as a driver for clinical precision, workflow optimization, and future-ready healthcare delivery requires coordinated strategy across technology, operations, and partnerships. Leaders who prioritize ecosystem implementation and resilient service will achieve measurable gains in diagnostics and patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Hybrid Imaging Market, by Technology Type
8.1. Pet-CT
8.2. Pet-MRI
8.3. Spect-CT
9. Hybrid Imaging Market, by Application
9.1. Cardiology
9.1.1. Myocardial Perfusion
9.1.2. Viability
9.2. Infectious Diseases
9.2.1. Infection Site Imaging
9.2.2. Inflammation Imaging
9.3. Neurology
9.3.1. Epilepsy
9.3.2. Neurodegenerative
9.4. Oncology
9.4.1. Hematologic Malignancies
9.4.2. Solid Tumors
10. Hybrid Imaging Market, by End User
10.1. Diagnostic Centers
10.2. Hospitals
10.3. Research Institutes
11. Hybrid Imaging Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Hybrid Imaging Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Hybrid Imaging Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Hybrid Imaging Market
15. China Hybrid Imaging Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Bruker Corporation
16.6. Canon Medical Systems Corporation
16.7. Cubresa Inc.
16.8. GE Healthcare Technologies Inc.
16.9. Mediso Medical Imaging Systems Ltd.
16.10. MILabs B.V.
16.11. Miltenyi Biotec B.V. & Co. KG
16.12. MR Solutions Ltd.
16.13. Philips Healthcare (Koninklijke Philips N.V.)
16.14. Raycan Technology Co., Ltd.
16.15. Siemens Healthineers AG
16.16. TriFoil Imaging, Inc.
List of Figures
FIGURE 1. GLOBAL HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HYBRID IMAGING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HYBRID IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HYBRID IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HYBRID IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HYBRID IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET-CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET-CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET-MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET-MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET-MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HYBRID IMAGING MARKET SIZE, BY SPECT-CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HYBRID IMAGING MARKET SIZE, BY SPECT-CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HYBRID IMAGING MARKET SIZE, BY SPECT-CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HYBRID IMAGING MARKET SIZE, BY MYOCARDIAL PERFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HYBRID IMAGING MARKET SIZE, BY MYOCARDIAL PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HYBRID IMAGING MARKET SIZE, BY MYOCARDIAL PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HYBRID IMAGING MARKET SIZE, BY VIABILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HYBRID IMAGING MARKET SIZE, BY VIABILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HYBRID IMAGING MARKET SIZE, BY VIABILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFECTION SITE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFECTION SITE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFECTION SITE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFLAMMATION IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFLAMMATION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HYBRID IMAGING MARKET SIZE, BY INFLAMMATION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HYBRID IMAGING MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HYBRID IMAGING MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HYBRID IMAGING MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HYBRID IMAGING MARKET SIZE, BY NEURODEGENERATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HYBRID IMAGING MARKET SIZE, BY NEURODEGENERATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HYBRID IMAGING MARKET SIZE, BY NEURODEGENERATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HYBRID IMAGING MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HYBRID IMAGING MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HYBRID IMAGING MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HYBRID IMAGING MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HYBRID IMAGING MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HYBRID IMAGING MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HYBRID IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HYBRID IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HYBRID IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HYBRID IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HYBRID IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HYBRID IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HYBRID IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HYBRID IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HYBRID IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HYBRID IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS HYBRID IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. EUROPE HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 98. EUROPE HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. EUROPE HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 101. EUROPE HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 102. EUROPE HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 103. EUROPE HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. AFRICA HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. AFRICA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 114. AFRICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. AFRICA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 116. AFRICA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 117. AFRICA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 118. AFRICA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 119. AFRICA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL HYBRID IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASEAN HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 131. ASEAN HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. ASEAN HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 134. ASEAN HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 135. ASEAN HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 136. ASEAN HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. GCC HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GCC HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 139. GCC HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. GCC HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 141. GCC HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 142. GCC HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 143. GCC HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 144. GCC HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. BRICS HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. BRICS HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 155. BRICS HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. BRICS HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 157. BRICS HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 158. BRICS HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 159. BRICS HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 160. BRICS HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. G7 HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. G7 HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 163. G7 HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. G7 HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 165. G7 HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 166. G7 HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 167. G7 HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 168. G7 HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. NATO HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. NATO HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 171. NATO HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. NATO HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 173. NATO HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 174. NATO HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 175. NATO HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 176. NATO HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. CHINA HYBRID IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. CHINA HYBRID IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 188. CHINA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. CHINA HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 190. CHINA HYBRID IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 191. CHINA HYBRID IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 192. CHINA HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 193. CHINA HYBRID IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Hybrid Imaging market report include:
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Cubresa Inc.
  • GE Healthcare Technologies Inc.
  • Mediso Medical Imaging Systems Ltd.
  • MILabs B.V.
  • Miltenyi Biotec B.V. & Co. KG
  • MR Solutions Ltd.
  • Philips Healthcare (Koninklijke Philips N.V.)
  • Raycan Technology Co., Ltd.
  • Siemens Healthineers AG
  • TriFoil Imaging, Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.19 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.72 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Hybrid Imaging - Global Strategic Business Report - Product Image

Hybrid Imaging - Global Strategic Business Report

  • Report
  • 231 Pages
  • Global
From
Clinical Molecular Imaging System Market - Global Forecast 2026-2032 - Product Image

Clinical Molecular Imaging System Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Nuclear Imaging Equipment Market - Global Forecast 2026-2032 - Product Image

Nuclear Imaging Equipment Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Nuclear Imaging Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Nuclear Imaging Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Brain Imaging Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Brain Imaging Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Hybrid Imaging Market

Hybrid Imaging is a type of medical imaging that combines two or more imaging modalities to create a single image. It is used to provide a more comprehensive view of a patient's anatomy and pathology than any single modality can provide. Hybrid Imaging is used in a variety of medical applications, including cardiology, oncology, neurology, and orthopedics. Hybrid Imaging combines the advantages of different imaging modalities, such as the high resolution of computed tomography (CT) and the high contrast of magnetic resonance imaging (MRI). This allows for more accurate diagnosis and treatment planning. Hybrid Imaging also reduces the amount of radiation exposure to the patient, as well as the time required for imaging. Some companies in the Hybrid Imaging market include Siemens Healthineers, Philips Healthcare, GE Healthcare, Canon Medical Systems, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.